Business OpportunityUpdated on 11 October 2025
Personalized peptide-based cancer immunotherapy
Head of Sales, Marketing & BD at Intavis Peptide Services
Tuebingen, Germany
About
We are a peptide manufacturer, based in Tuebingen, Germany. Our focus lies on the chemical synthesis of lower amounts of high quality peptide products. We are therefore strongly involved in the high quality manufacturing of peptides that are used in compassionate use and clinical testing of individualized cancer immunotherapy. Our focus on this scale, agility and high quality production allows us to serve these individualized therapy approaches.
Stage
- TRL 6
- TRL 7
- TRL 8
Topic
- Bioinformatics
- Infectious and parasitic diseases
- Neoplasms/cancer/oncology
- Proteomics
Sector
- ATMPs
- Diagnostics
- Oncology
Type
- Research collaboration
- Clinical validation
- Consortium partners
Attached files
Organisation
Similar opportunities
Business Opportunity
- AI
- TRL 7
- Oncology
- Diagnostics
- Bioinformatics
- Clinical validation
- Consortium partners
- Neoplasms/cancer/oncology
Marc Vargas
Project Manager in Digital Pathology at Palex
Barcelona, Spain
Business Opportunity
Preclinical Platform for ATMP Evaluation with Patient-Derived Microtumours (PDMs)
- AI
- TRL 6
- ATMPs
- Genomics
- Oncology
- Proteomics
- Health data
- Diagnostics
- Bioinformatics
- Co-development
- Regulatory expert
- Consortium partners
- Research collaboration
- Neoplasms/cancer/oncology
Martin Kriebel
Group Leader (dep.) Cellular & Molecular Biology at NMI Natural and Medical Sciences Institute
Reutlingen, Germany
Business Opportunity
Cell Apoptotic Response: Real-time tracking of apoptosis for functional precision medicine
- TRL 6
- Other
- Other
- Oncology
- Physiology
- Health data
- Diagnostics
- Bioinformatics
- Clinical validation
- Neoplasms/cancer/oncology
Zoi Melissari
IBEC - Technology Transfer and Business Development manager at Institute for Bioengineering of Catalonia (IBEC)
Spain